Log in with your email address username.

×

[Department of Error] Department of Error

Le Roux CW , Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 2017; 389: 1399–409—In table 1 of this Article, some rounding errors in the percentages have been amended. Additionally, the y-axis scale for figure 2C was incorrect. The y-axis scale has been amended to –0·6 to 2. These corrections have been made to the online version as of March 14, 2017, and the printed Article is correct.

email